Back to Search

A Phase 2a/2b, Open-label, Proof of Concept (Phase 2a) and Double-blind, Randomized, Placebo-Controlled (Phase 2b), Multicenter, Efficacy, and Safety Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes

  • Protocol Number: 202208129
  • Principal Investigator: Jacoby, Meagan
  • Cancer Types: Leukemia, Myeloma, and Hematologic

For more information on this trial, contact us here:


Brief Summary

Protocol Interventions